HOME     CONTACT     BACK

 
 
 
THE PHARMA REVIEW (JULY - AUGUST 2010)

Counterfeit Drugs: Problems and Solutions

Kapil Bhargava

Abstract
According to the WHO definition, a counterfeit drug is “a medicine, which is deliberately and fraudulently mis-labeled with respect to identity and/or source. Counterfeiting can apply to both branded and generic products and counterfeit products may include products with the correct ingredients or with the wrong ingredients, without active ingredients, with insufficient active ingredients or with fake packaging”. Such drugs have harmful effect on patients as not having the desired effect is also harmful for patient under treatment which may lead to death in several cases. In our country’s drug legislation, the word “counterfeit” does not exist and this type of products are termed as “adulterated and spurious”. These have been defined in Drugs Act with similar meaning as termed above by WHO. It further mentioned that “counterfeit medicines and other health products are also detrimental to public health efforts to deal with disease in countries which are already stretched thin with limited resources for health care”.

 

For full text of this article contact the publisher on info@kppub.com

 

Go to Content Index Page

PHARMA REVIEW - ARTICLES ARCHIVE ( COMPLETE LIST)

The above content is an abstract only. For the full Article please contact:
KONGPOSH Publications Pvt. Ltd.
ICS House, C-19, Commercial Complex, SDA, Opp. IIT Gate, New Delhi, India -110016
Tel.: 26855839, 20057149, Fax: 91-11-26855876
Email: info@kppub.com / fpc@vsnl.com, Website: http://www.kppub.com

 
 
 

 Copyright 2008. KONGPOSH PUBLICATIONS Pvt. Ltd.